Company Overview:
Beam Therapeutics is committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Beam is looking for a highly motivated, strategic and driven commercial leader to join our growing Product & Portfolio Strategy team. The Senior Director, BEAM-101 Brand Strategy Lead will drive brand strategy development, commercial launch readiness and execution for Beam’s lead asset, BEAM-101, an ex vivo autologous hematopoietic stem cell-based gene therapy for the treatment of severe sickle cell disease (SCD). This is a high impact role for Beam’s potential first product commercialization. The successful candidate plays a critical role in building the marketing and field teams and in establishing commercial operations readiness for the company.
The Senior Director, BEAM-101 Brand Strategy Lead, reports into the VP, Product & Portfolio Strategy, Hematology, and the latter is also the cross-functional launch lead for BEAM-101.
Responsibilities:
- Develops and leads brand strategy for BEAM-101 and ensures alignment across key cross-functional stakeholders including Medical, Market Access, and Technical Operations.
- Owns development of brand positioning, messaging, and competitive strategy.
- Leads commercial launch readiness and execution in close collaboration with cross-functional partners.
- Directs HCP marketing strategy and oversees tactical execution by agency partners and future HCP marketers.
- Builds and leads team of marketing professionals.
- Oversees generation of customer and market insights through primary and secondary research, competitive intelligence and Advisory Boards.
- Leads scenario planning, risk management, and contingency strategies for launch, including forecasting and supply chain coordination.
- Budget management.
Qualifications:
- BS/BA in a relevant academic field; MBA, MD, PhD, or other graduate degree strongly preferred.
- Minimum 12 years business experience within the pharma/biotech/biopharma space.
- Proven track record of developing and executing brand strategies in highly cross-functional environments.
- Experience in cell therapy is a must.
- U.S. launch experience is a must.
- Outstanding strategic thinking and problem-solving capabilities.
- Must be capable of managing and prioritizing multiple activities.
- Can operate in two worlds — big picture orientation with attention to detail.
- Exceptional interpersonal skills and collaborative nature with strong ability to influence, motivate, inspire, encourage and develop others.
- Demonstrated people management experience and development capabilities required.
- Builds effective teams that work well across functions and groups.
- Strong business and financial capabilities.
- Advanced communication and presentation skills required.
- Experience in both large and small company environments a plus.
- Role is based in Cambridge, MA, or hybrid.
- Ability to travel 25% as needed.
Top Skills
Beam Therapeutics Cambridge, Massachusetts, USA Office
238 Main ST, Cambridge, Massachusetts , United States, 02142
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories